Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and … Read more

RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say

RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. leaves the stage after discussing the findings of the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, at the Department of Health and Human Services in Washington, D.C., U.S., April 16, 2025. Elizabeth Frantz | Reuters … Read more

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead … Read more

Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access

Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A wave of outrage is sweeping the scientific and medical world after Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to stop recommending routine Covid-19 … Read more

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight … Read more

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated … Read more

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.

Rafael Henrique | Lightrocket | Getty Images Shares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and Human Services Secretary Robert F. Kennedy Jr.’s views on immunization. The departure of Peter Marks, the Food and Drug Administration’s top vaccine regulator, has raised fresh fears about … Read more

Moderna (MRNA) Q4 earnings 2024

Moderna (MRNA) Q4 earnings 2024

Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls.  It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline … Read more